POM-V Prescription Required

BioEquin FT Suspension for Injection for Horses

Active ingredients: Clostridium tetani, Equine influenza virus

Form

Injection

Species

Horses

Manufacturer

Bioveta, a.s.

VMD MA No.

46608/3006

What it's used for

Influenza: Onset of immunity: 2 weeks after basic vaccination Duration of immunity: 6 months after basic vaccination and 12 months after first revaccinatio...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Clostridium tetani + Equine...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

BioEquin FT Suspension for Injection for Horses — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Influenza:
Onset of immunity: 2 weeks after basic vaccination
Duration of immunity: 6 months after basic vaccination and 12 months after first
revaccination.
The onset of immunity was demonstrated by challenge test for equine influenza strain
A/Equi 2/Brno 08 and equine influenza strain A/Equi 2/Limerick 2010.
The duration of immunity of the vaccine equine influenza strains A/Equi 2/Brno08 and
A/Equi 2/Limerick 2010 was demonstrated by serology.
Tetanus:
Onset of immunity: 2 weeks after basic vaccination
Duration of immunity: 6 months after basic vaccination and 12 months after first
revaccination.

aseptic method.
The contents of the vial should reach a temperature of 15-25 °C and should be shaken
thoroughly before use.
Vaccination schedule:
Basic vaccination:
First vaccination from 6 months of age, second vaccination 4 weeks later.
Revaccination:
First revaccination 6 months after basic vaccination and further revaccination is carried
out at the latest at intervals of 12 months.
Revaccination of pregnant mares in the last trimester of pregnancy is carried out not later
than one month prior to a scheduled foaling date.

None.

Horses:
Very common
(>1 animal / 10 animals
treated):
Injection site swelling.
Elevated temperature.
Very rare
(<1 animal / 10 000 animals
treated, including isolated
reports):
Injection site abscess, Anaphylactic reaction.
1
Up to 1 °C for 1-3 days.
In such a case, symptomatic treatment is required.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

Vaccinate healthy animals only. It is recommended not to exercise the horse for 2-3
days after vaccination.

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.

No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case-by-case
basis.

Store in a refrigerator (2 C – 8 C).
Protect from frost.
Protect from light.
Store in a dry place.

Zero days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.